CPhI Experts Comment on Urgent Regulatory Change

Malhotra argues that for far too long we have allowed the status quo to continue, and that for true continual improvement we need to make it easier for companies to make vital alterations to manufacturing processes, without being hindered by a full re-approval process.   Under his guidelines the #pharmaceutical industry will be allowed to […]